World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
14949
World Ranking
9159
National Ranking
615

Hirokazu Tamamura publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Hirokazu Tamamura sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 351 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Hirokazu Tamamura D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Hirokazu Tamamura sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Hirokazu Tamamura is affiliated with Tokyo Medical and Dental University in Japan. Their research career spans multiple domains primarily focused on medicine, biochemistry, genetics, molecular biology, immunology, and microbiology. The scientist has contributed to 44 publications in the field of medicine and 37 in biochemistry, genetics, and molecular biology, with additional work in immunology and microbiology.

The research subfields include molecular biology, infectious diseases, virology, organic chemistry, and immunology. These areas underpin investigations into various significant topics, notably HIV research and treatment, HIV/AIDS drug development and treatment, chemical synthesis and analysis, click chemistry applications, and research related to SARS-CoV-2 and COVID-19. They have also contributed to computational drug discovery methods and explored synthesis and biological activity.

Frequent coauthors collaborating with Tamamura include:

  • Kohei Tsuji
  • Takuya Kobayakawa
  • Takahiro Ishii
  • Hiroaki Mitsuya
  • Kouki Shinohara

Publishing venues where Tamamura's work has appeared multiple times include:

  • Bioorganic & Medicinal Chemistry
  • Journal of Medicinal Chemistry
  • RSC Chemical Biology
  • Chemical and Pharmaceutical Bulletin
  • Organic & Biomolecular Chemistry

Recent publications reflect active involvement in infectious disease research as well as chemical biology and drug discovery:

  • "A cell cycle-dependent CRISPR-Cas9 activation system based on an anti-CRISPR protein shows improved genome editing accuracy," 2020, Communications Biology
  • "Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2," 2023, Nature Communications
  • "Potent and biostable inhibitors of the main protease of SARS-CoV-2," 2022, iScience
  • "Structure-Activity Relationship Studies of SARS-CoV-2 Main Protease Inhibitors Containing 4-Fluorobenzothiazole-2-carbonyl Moieties," 2023, Journal of Medicinal Chemistry
  • "Small-Molecule Anti-HIV-1 Agents Based on HIV-1 Capsid Proteins," 2021, Biomolecules

Best Publications

  • Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5.

    Christopher D C Allen;K Mark Ansel;K Mark Ansel;Caroline Low;Robin Lesley

  • A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

    Tsutomu Murakami;Toshihiro Nakajima;Yoshio Koyanagi;Kazunobu Tachibana

  • A low-molecular-weight inhibitor against the chemokine receptor CXCR4: a strong anti-HIV peptide T140.

    Hirokazu Tamamura;Younong Xu;Toshio Hattori;Xiaoyan Zhang

  • T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer

    Hirokazu Tamamura;Akira Hori;Naoyuki Kanzaki;Kenichi Hiramatsu

  • Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells

    Meike Burger;Tanja Hartmann;Tanja Hartmann;Myriam Krome;Myriam Krome;Justyna Rawluk;Justyna Rawluk

  • Bioluminescence resonance energy transfer reveals ligand-induced conformational changes in CXCR4 homo- and heterodimers

    Yann Percherancier;Yamina A. Berchiche;Isabelle Slight;Rudolf Volkmer-Engert

  • HIV protease inhibitor nelfinavir inhibits replication of SARS-associated coronavirus.

    Norio Yamamoto;Rongge Yang;Yoshiyuki Yoshinaka;Shinji Amari

  • CXCL12-CXCR4 engagement is required for migration of cutaneous dendritic cells.

    Kenji Kabashima;Noriko Shiraishi;Kazunari Sugita;Tomoko Mori

  • A point mutation that confers constitutive activity to CXCR4 reveals that T140 is an inverse agonist and that AMD3100 and ALX40-4C are weak partial agonists.

    Wen-bo Zhang;Jean-Marc Navenot;Bodduluri Haribabu;Hirokazu Tamamura

  • Molecular‐Size Reduction of a Potent CXCR4‐Chemokine Antagonist Using Orthogonal Combination of Conformation‐ and Sequence‐Based Libraries

    Nobutaka Fujii;Shinya Oishi;Kenichi Hiramatsu;Takanobu Araki

  • Elevated Serum Levels of Stromal-Derived Factor-1α Are Associated with Increased Osteoclast Activity and Osteolytic Bone Disease in Multiple Myeloma Patients

    Andrew C.W. Zannettino;Amanda N. Farrugia;Angela Kortesidis;Jim Manavis

  • Remodeling of gp41‐C34 Peptide Leads to Highly Effective Inhibitors of the Fusion of HIV‐1 with Target Cells

    Akira Otaka;Miki Nakamura;Daisuke Nameki;Eiichi Kodama

  • A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)

    Masao Masuda;Hideki Nakashima;Toshihiro Ueda;Hiroyasu Naba

  • Identification of a CXCR4 antagonist, a T140 analog, as an anti-rheumatoid arthritis agent.

    Hirokazu Tamamura;Miho Fujisawa;Kenichi Hiramatsu;Makiko Mizumoto

  • T134, a Small-Molecule CXCR4 Inhibitor, Has No Cross-Drug Resistance with AMD3100, a CXCR4 Antagonist with a Different Structure

    Rieko Arakaki;Hirokazu Tamamura;Mariappan Premanathan;Kenji Kanbara

  • Stromal cell-derived factor 1-mediated CXCR4 signaling in rat and human cortical neural progenitor cells.

    Hui Peng;Yunlong Huang;Jeremy Rose;David Erichsen

  • Pharmacophore identification of a specific CXCR4 inhibitor, T140, leads to development of effective anti-HIV agents with very high selectivity indexes.

    Hirokazu Tamamura;Akane Omagari;Shinya Oishi;Taisei Kanamoto

  • Lipid bilayer simulations of CXCR4 with inverse agonists and weak partial agonists.

    John O. Trent;Zi-xuan Wang;James L. Murray;Wenhai Shao

  • Development of specific CXCR4 inhibitors possessing high selectivity indexes as well as complete stability in serum based on an anti-HIV peptide T140.

    Hirokazu Tamamura;Akane Omagari;Kenichi Hiramatsu;Kazuyo Gotoh

  • A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.

    Hirokazu Tamamura;Masataka Kuroda;Masao Masuda;Akira Otaka

Frequent Co-Authors

Nobutaka Fujii
Nobutaka Fujii Kyoto University
Akira Otaka
Akira Otaka University of Tokushima
Naoki Yamamoto
Naoki Yamamoto Kyoto University
Shinya Oishi
Shinya Oishi Kyoto University
Stephen C. Peiper
Stephen C. Peiper Thomas Jefferson University
Yoshinori Yamamoto
Yoshinori Yamamoto Tohoku University
John O. Trent
John O. Trent University of Louisville
Hiroaki Ohno
Hiroaki Ohno Kyoto University
Kazuhisa Yoshimura
Kazuhisa Yoshimura National Institutes of Health
Peter M. Blumberg
Peter M. Blumberg National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Hirokazu Tamamura

Trending Scientists

Recently Published Articles